In this situation, the increased levels of vascular growth factors within the tumor microenvironment can promote tumorigenesis, triggered by FLT4 amplification (encoding VEGFR3) and KDR mutation (encoding VEGFR2). The gene discussed is KDR; the disease is neoplasm.